The door is not only being opened to allow Travelan in but it is being removed from its hinges and thrown away. Growing antibiotic resistance must/will/should be a significant factor in FDA decision making on Immuron's present application to take Travelan to Phase 3 trials:
https://www.msn.com/en-au/news/australia/patients-face-return-trips-to-doctor-under-proposed-ban-on-antibiotic-repeat-prescriptions/ar-AAIu9Db?ocid=spartandhp
The door is not only being opened to allow Travelan in but it is...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $23.93M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 11.0¢ | 10.5¢ | $27.18K | 258.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 320829 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 4965 | 1 |
View Market Depth
| Last trade - 15.38pm 27/09/2024 (20 minute delay) ? |
| IMC (ASX) Chart |